Mark Yat-fung Chiang, MD - Medicare Hematology in Ann Arbor, MI

Mark Yat-fung Chiang, MD is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in Ann Arbor, Michigan. He went to Perelman School Of Med At The University Of Pennsylvania and graduated in 2001 and has 23 years of diverse experience with area of expertise as Hematology. He is a member of the group practice Regents Of The University Of Michigan and his current practice location is 1500 E Medical Center Dr, B1 Floor Cancer Recp B, Ann Arbor, Michigan. You can reach out to his office (for appointments etc.) via phone at (734) 936-6000.

Mark Yat-fung Chiang is licensed to practice in Michigan (license number 4301095754) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1720034986.

Contact Information

Mark Yat-fung Chiang, MD
1500 E Medical Center Dr, B1 Floor Cancer Recp B,
Ann Arbor, MI 48109-5911
(734) 936-6000
Not Available



Physician's Profile

Full NameMark Yat-fung Chiang
GenderMale
SpecialityHematology
Experience23 Years
Location1500 E Medical Center Dr, Ann Arbor, Michigan
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Mark Yat-fung Chiang attended and graduated from Perelman School Of Med At The University Of Pennsylvania in 2001
  NPI Data:
  • NPI Number: 1720034986
  • Provider Enumeration Date: 05/26/2006
  • Last Update Date: 03/25/2010
  Medicare PECOS Information:
  • PECOS PAC ID: 9638176241
  • Enrollment ID: I20100316000877

Medical Identifiers

Medical identifiers for Mark Yat-fung Chiang such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1720034986NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RH0003XInternal Medicine - Hematology & Oncology MD422545 (Pennsylvania)Secondary
207RH0003XInternal Medicine - Hematology & Oncology 4301095754 (Michigan)Primary
207R00000XInternal Medicine 4301095754 (Michigan)Secondary
207RH0000XInternal Medicine - Hematology 4301095754 (Michigan)Secondary
207RX0202XInternal Medicine - Medical Oncology 4301095754 (Michigan)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
University Of Michigan Health SystemAnn arbor, MIHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Regents Of The University Of Michigan37794968562916

News Archive

Cancer drug could help inhibit adenovirus infection

An adenovirus infection can be potentially life-threatening, especially for children after a stem cell transplant.

Geisinger Health System is one among six healthcare organizations in U.S. invited to join Med-IC

Geisinger Health System is one of only six healthcare organizations in the United States invited by the Mount Sinai School of Medicine and Johns Hopkins University to participate in a new pilot program, Medicare Innovations Collaborative (Med-IC). Med-IC is a national effort to change healthcare policy and improve healthcare for older adults by putting the leading models of geriatric best practices to work in hospital settings.

Wound Repair and Regeneration publishes positive findings from CXM's Matrix Phase 2b clinical study

Cardium Therapeutics today announced the publication of positive findings from the Company's Matrix Phase 2b clinical study.

Phase 2a clinical trial results of CPEX Pharmaceuticals' Nasulin insulin

CPEX Pharmaceuticals Inc. today reported preliminary results related to its Phase 2a proof-of-concept clinical trial of the Company's nasal insulin product, Nasulin™. The study was designed to evaluate the efficacy and safety of Nasulin versus placebo over a 6-week treatment period in subjects with Type 2 diabetes who were being treated with basal insulin and oral anti-diabetes agents.

Researchers use dynamic time-series data to help improve accuracy of genome mapping

If you already have the sequenced map of an organism's genome but want to look for structural oddities in a sample, you can check the genomic barcode - a series of distances between known, targeted sites - by cutting a DNA sequence at those sites and examining the distance between the cuts.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Mark Yat-fung Chiang allows following entities to bill medicare on his behalf.
Entity NameRegents Of The University Of Michigan
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1205868353
PECOS PAC ID: 3779496856
Enrollment ID: O20031106000325

News Archive

Cancer drug could help inhibit adenovirus infection

An adenovirus infection can be potentially life-threatening, especially for children after a stem cell transplant.

Geisinger Health System is one among six healthcare organizations in U.S. invited to join Med-IC

Geisinger Health System is one of only six healthcare organizations in the United States invited by the Mount Sinai School of Medicine and Johns Hopkins University to participate in a new pilot program, Medicare Innovations Collaborative (Med-IC). Med-IC is a national effort to change healthcare policy and improve healthcare for older adults by putting the leading models of geriatric best practices to work in hospital settings.

Wound Repair and Regeneration publishes positive findings from CXM's Matrix Phase 2b clinical study

Cardium Therapeutics today announced the publication of positive findings from the Company's Matrix Phase 2b clinical study.

Phase 2a clinical trial results of CPEX Pharmaceuticals' Nasulin insulin

CPEX Pharmaceuticals Inc. today reported preliminary results related to its Phase 2a proof-of-concept clinical trial of the Company's nasal insulin product, Nasulin™. The study was designed to evaluate the efficacy and safety of Nasulin versus placebo over a 6-week treatment period in subjects with Type 2 diabetes who were being treated with basal insulin and oral anti-diabetes agents.

Researchers use dynamic time-series data to help improve accuracy of genome mapping

If you already have the sequenced map of an organism's genome but want to look for structural oddities in a sample, you can check the genomic barcode - a series of distances between known, targeted sites - by cutting a DNA sequence at those sites and examining the distance between the cuts.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mark Yat-fung Chiang is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Mark Yat-fung Chiang, MD
3621 S State St, 700 Kms Place,
Ann Arbor, MI 48108

Ph: (734) 936-2047
Mark Yat-fung Chiang, MD
1500 E Medical Center Dr, B1 Floor Cancer Recp B,
Ann Arbor, MI 48109-5911

Ph: (734) 936-6000

News Archive

Cancer drug could help inhibit adenovirus infection

An adenovirus infection can be potentially life-threatening, especially for children after a stem cell transplant.

Geisinger Health System is one among six healthcare organizations in U.S. invited to join Med-IC

Geisinger Health System is one of only six healthcare organizations in the United States invited by the Mount Sinai School of Medicine and Johns Hopkins University to participate in a new pilot program, Medicare Innovations Collaborative (Med-IC). Med-IC is a national effort to change healthcare policy and improve healthcare for older adults by putting the leading models of geriatric best practices to work in hospital settings.

Wound Repair and Regeneration publishes positive findings from CXM's Matrix Phase 2b clinical study

Cardium Therapeutics today announced the publication of positive findings from the Company's Matrix Phase 2b clinical study.

Phase 2a clinical trial results of CPEX Pharmaceuticals' Nasulin insulin

CPEX Pharmaceuticals Inc. today reported preliminary results related to its Phase 2a proof-of-concept clinical trial of the Company's nasal insulin product, Nasulin™. The study was designed to evaluate the efficacy and safety of Nasulin versus placebo over a 6-week treatment period in subjects with Type 2 diabetes who were being treated with basal insulin and oral anti-diabetes agents.

Researchers use dynamic time-series data to help improve accuracy of genome mapping

If you already have the sequenced map of an organism's genome but want to look for structural oddities in a sample, you can check the genomic barcode - a series of distances between known, targeted sites - by cutting a DNA sequence at those sites and examining the distance between the cuts.

Read more News

› Verified 3 days ago


Internal Medicine Doctors in Ann Arbor, MI

Nabil Alkhoury Fallouh, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 1500 East Medical Center Dr, 3rd Floor Taubman Ctr Recp B, Ann Arbor, MI 48109
Phone: 734-936-5582    
Sameer Dev Saini, M.D.
Hematology & Oncology
Medicare: Medicare Enrolled
Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109
Phone: 734-936-4000    
Dr. David Alexander Stewart, M.D.
Hematology & Oncology
Medicare: Medicare Enrolled
Practice Location: 1500 E Medical Center Dr, 12th Floor C.s. Mott Children's Hospital Room 525, Ann Arbor, MI 48109
Phone: 734-763-5302    Fax: 734-647-5624
Dr. Aiman M Mahmood, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 1500 E Medical Center Dr, Med Inn C728, Ann Arbor, MI 48109
Phone: 734-998-0891    
Anastasia Irene Wasylyshyn, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109
Phone: 734-936-4000    
Katherine Saber Salisbury, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 4260 Plymouth Rd, Ann Arbor, MI 48109
Phone: 734-764-6831    
Anne Lewis Carlton,
Hematology & Oncology
Medicare: Not Enrolled in Medicare
Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109
Phone: 734-647-5900    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.